GDPR, CCPA & What They Mean for Your Business and Your Clinical Trials

Having come into effect on May 25, 2018, with sweeping extraterritorial jurisdiction and large potential fines, the European General Data Protection Regulation (GDPR) imposes obligations on MedTech companies and how they process the data of their patients, customers, and clinical trial subjects ... even if they do not have an EU subsidiary or parent company. Fast on the heels of GDPR comes the California Consumer Privacy Act (CCPA), which, starting in 2020, will impose expanded disclosure rights and grant individuals rights in their data.

In this breakout session we will discuss how GDPR applies to you, what risks are involved, how to mitigate them, how this all affects your EU clinical trials, and how CCPA will fit into the picture.